National PostNew Lyme disease vaccine shows promise in clinical trials
A new Lyme disease vaccine, PF-07307405, has demonstrated over 70% efficacy in preventing the disease after four doses, according to Pfizer and Valneva's Phase 3 clinical trial results. The vaccine is currently in develo
2d agolyme-diseasevaccine